Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended: May 31, 1998
Commission File Number: 0-11050

                              Mammatech Corporation
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


            Florida                                            59-2181303
--------------------------------------------------------------------------------
(State or other jurisdiction of                           (I.R.S. Employer
incorporation or organization)                            Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                         32601
--------------------------------------------------------------------------------
(Address of principal executive offices)                        (Zip Code)


                                 (352) 375-0607
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes___X____No_______

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                                 Number of shares outstanding on

                                                           May 31, 1998
                                                 -------------------------------
                                                 100,352,500 shares of which
                                                 7,408,500 are treasury shares
TITLE OF EACH CLASS
-------------------
Common stock $.0001 par value

The total number of pages of this report is 11

<PAGE>



                              Mammatech Corporation

                                      INDEX
--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                                PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended May 31, 1998 and May 31, 1997....................3

         Balance Sheets for May 31, 1998
         August 31, 1997......................................4-5

         Statement of Cash Flow for the Quarter
         Ended May 31, 1998.....................................6

         Statements of Cash Flow for the Quarter
         Ended May 31, 1997.....................................7

         Notes to Financial Statements for the Quarter
         Ended May 31, 1998.....................................8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations.........9


PART II.     OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K.............10

         SIGNATURES........................................... 11





                                       -2-
<PAGE>
<TABLE>
<CAPTION>

                                  Mammatech Corporation
                                Statements of Operations
                                       (Unaudited)

                                Nine Months Ended                 Three Months Ended
                                May            May                 May           May
                                1998           1997                1998          1997
                                ----           ----                ----          ----

<S>                         <C>                 <C>           <C>                  <C>   
Sales, net                  $    365,314        253,743       $    142,835         78,231

Cost of sales                    103,020         79,326             38,886         28,530
                            ------------   ------------       ------------   ------------

Gross Profit                     262,294        174,417            103,949         49,701
Selling,general
and adminstra-
tive expense                $    226,016        132,063            133,303         39,350
                            ------------   ------------       ------------   ------------


Operating Income                  36,278         42,354             29,354         10,351
                            ------------   ------------       ------------   ------------
    (Loss)

Other income
(expense)
 Interest &
 Dividend Income                  13,063          7,307              4,564          2,743

 SBIR Grant                      103,088                            37,697
    reimb

Utilization of oper 
loss carryforward                    -0-          9,932                -0-          2,618
                                           ------------                      ------------


Net income before
   taxes                         152,429         59,593             12,907
Provision for income
   tax                               -0-          9,932                -0-          2,618


NET INCOME (LOSS)                152,429         59,593             12,907         13,094
                            ------------   ------------       ------------   ------------

Net income (loss)
per share                          .0015          .0005              .0001          .0001
                            ============   ============       ============   ============

Weighted
average shares               100,352,500    100,352,500        100,352,500    100,352,500
                            ============   ============       ============   ============


        The accompanying notes are an integral part of the financial statements.

                                           -3-
</TABLE>

<PAGE>


                              Mammatech Corporation

                                 Balance Sheets


                                                May 31, 1998      Aug. 31, 1997
                                                 (Unaudited)        (Audited)
                                                 -----------        ---------


ASSETS
------

  Cash and Cash Equivalents                        $274,139          169,088
    Marketable Securities                            82,752           82,752

  Accounts receivable:
    Trade                                            69,070           62,745
    Other                                             3,190            3,236


  Inventory                                         197,205          162,019
 Other current assets                                  --               --

  Total Current Assets                              626,364          479,840

Property and equipment                               54,609           49,082

Other assets:


  Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $53,080 and $46,942
    respectively                                     10,233            1,262
                                                   --------         --------

             Total other assets                      10,233            1,262
                                                   --------         --------

TOTAL ASSETS                                       $691,198         $530,184



    The accompanying notes are an integral part of the financial statements.

                                       -4-

<PAGE>


                              Mammatech Corporation
                                 Balance Sheets

                              As of August 31, 1997
                                and May 31, 1998
                                   (continued)

                                                   May 1998          Aug 1997
                                                   --------          --------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES
-------------------
Accounts payable-trade                            $    48,923       $    38,722
Accrued payable-officer                                 6,630             6,630
Short term debt                                           910             3,578
Accrued expenses                                       59,567            58,368
                                                  -----------       -----------

TOTAL CURRENT LIABILITIES                             116,030           107,298


COMMITMENTS
 Long term dept                                         5,527             5,527

Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  80,352,500 shares issued
  and outstanding                                 $    10,035       $    10,035

  Additional paid-in capital                        2,809,594         2,809,594
  Accumulated deficit                              (2,108,189)       (2,260,471)
                                                  -----------       -----------
                                                  -----------       -----------
                                                      711,440           559,158

  Valuation allowance for
    marketable securities                               6,252             6,252

  Treasury stock at cost,
  7,408,500 shares                                   (148,051)         (148,051)
                                                  -----------       -----------
                                                      569,641           417,359



TOTAL LIABILITIES AND                             $   691,198       $   530,184
STOCKHOLDERS' EQUITY


        The accompanying notes are an integral part of these statements.

                                       -5-
<PAGE>


                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Nine Months Ending
                                  May 31, 1998



Net cash flow from operating activities                                   99,524
                                                                        ========

Investing Activities:
         Sale of certificate of deposit                                      -0-
         Purchase of furniture and fixtures                                5,527


Financing activities:



Net increase (decrease) in cash                                          105,051


Beginning cash                                                           169,088
                                                                        --------

Ending cash                                                             $274,139
                                                                        ========


                                       -6-

<PAGE>

                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Nine Months Ending
                                  May 31, 1997


Net cash flow from operating activities                                 11,688
                                                                      ========

Investing Activities:
         Sale of certificate of deposit                                    -0-
         Purchase of furniture and fixtures                              7,086


Financing activities:



Net increase (decrease) in cash                                         (4,602)


Beginning cash                                                         179,651
                                                                      --------

Ending cash                                                           $175,049
                                                                      ========

                                       -7-


<PAGE>

                              Mammatech Corporation
                          Notes to Financial Statements
                                  May 31, 1998



Note 1.   In the opinion of the Company,  the accompanying  unaudited  financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of May 31,  1998,  and the  results of  operations  and  changes in
          financial position for the three months ended May 31, 1998.


Note 2.   Loss per  share is based on the  weighted  average  number  of  shares
          outstanding during each period.

Note 3.   Gives effect to the Company's  repurchasing  7,558,500 shares of stock
          from shareholders for treasury stock.



                                       -8-





<PAGE>

                MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
          CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION

The third quarter of Fiscal 1998 was a substantial improvement over the previous
quarter and over the third quarter from a one year ago.  Sales were up 201% over
the previous  quarter and were 82.4% greater than sales during the third quarter
of 1997.  Operating  income of $29,354  reflects  an  increase  of 183% from the
previous year and compares  favorably with the $42,276 loss  experienced  during
the previous  quarter.The net income for the current quarter was 2750% above the
$453 reported for the previous quarter.

The nine month  figures  show a 44% increase in sales for the current year but a
14% decline in operating income. Comparisons among other nine-month figures from
a year ago are  affected  by the fact that the  Company is now  administering  a
Phase II SBIR grant that added to both its operating  expense and net income for
the period.  Thus, for example,  the  nine-month  figure for net income for this
year   is   156%    greater   than   the    corresponding    figure   for   last
year.Similarly,operating  expense  increased  by 68%  compared  with a year  ago
whereas cost of sales increased by only 29.9% .

During  the  quarter,the  Company  extended  its  relationship  with its  German
distributor  by training 3 health care  professionals  (two  physicians  and one
nurse) as  MammaCare  Specialists.  This will  provide  the basis for  extensive
outreach to the medical community in Germany which will, the Company hopes, help
solidify  acceptance  of the  MammaCare  technology  among  the  women  of  that
country.The  Company  also  trained  six  additional  specialists,  including  a
physician  from a major  medical  school who will be  introducing  the MammaCare
method of clinical breast examination to resident training in that institution.

The Company also made a  substantial  sale of breast  models and other  training
materials to the American Medical Women's  Association for their use in training
U.S. military personnel and their dependents. Many of these are follow-up orders
from  similar  sales made last year.  The Company made a major sale of specially
constructed  breast  models  to  the  California   Department  of  Health.  That
organization is actively  disseminating a program of clinical breast examination
training using the Company's products and  procedures.There can be no assurance,
however,  that any of these customers will continue to procure  materials at the
present rate or that substantial revenues will accrue to the Company as a result
of their involvement.

Finally,  the Company  introduced  two new products  during the quarter.  It has
added  dark-skinned  models to the Home Practice  Series in response to numerous
requests,  particularly  from American Cancer Society units. It also added a new
evaluation  lamp which  projects the MammaCare  grid on the torso of the patient
being trained or examined. This grid provides a basis for precise measurement of
the  examination  performance,  a hallmark of the MammaCare  procedure since its
days in the laboratory.


The  Company  remains  essentially  debt-free  and  has no  immediate  liquidity
problems.  It  continues to pursue a corporate  affiliation  designed to help it
realize the full commercial potential of its products.

                                       -9-



<PAGE>

                           PART II - OTHER INFORMATION
                           ---------------------------




Item 6.   Exhibits and Reports on Form 8-K

   (a.)   Exhibits - None

   (b.)   There were no reports filed on Form 8-K during the three months ending
          May 31, 1998.



                                      -10-

<PAGE>

                                      10-Q

                     For the three months ended May 31, 1998

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION

DATE:  July 6, 1998                    BY: /s/ Henry S. Pennypacker
     ------------------------------       --------------------------------------
                                          Henry S. Pennypacker, President
                                          and Director

BY: /s/ Mary Sellers
   --------------------------------
   Mary Sellers, Treasurer and
   Chief Financial Officer


                                      -11-